Dr. Alexandre Dumais is a psychiatrist at the Institut National de Psychiatrie Légale Philippe-Pinel, a researcher at the Centre de Recherche de l’Institut Universitaire en Santé Mentale de Montréal and a
clinical professor at the University of Montreal. During his residency in psychiatry, he completed a doctorate in biomedical sciences. In 2019, he obtained the status of junior clinical fellow researcher from the Fonds de Recherche Santé Québec. He was awarded the Prize for Best Research Work from the
Association of Psychiatrist Doctors of Quebec (AMPQ) in 2009, the Award for Best Scientific Achievement from the Department of Psychiatry in 2010, and the Ella Amir Prize for innovations in mental health, AMI-Québec in 2018. His main research projects focus on the neurobiology and treatment of patients with mental health disorders.
Marc Lavoie is currently a research professor of Psychiatry and Neuroscience at the University of Montréal, and since 2001, he has been directing the Cognitive and Social Psychophysiology Laboratory, at the research center of the Institut Universitaire en Santé Mentale de Montréal (Canada). His research training was completed in the fields of psychophysics (Université de Moncton, Canada), experimental neuropsychology (Université de Montréal, Canada), developmental psychology (Universiteit van Amsterdam, Nederland) and psychobiology (Université de Lille, France). He directs a clinical research program that addresses crucial issues about the relationship between brain functions, behavior, and cognition in various neurodevelopmental and habit disorders, primarily in Tourette syndrome and body-focused repetitive behavior. He is a member of the International Organization of Psychophysiology. He is particularly interested in the physiological effects of non-drug treatments to assess and treat these disorders. He is also interested in the sexual differences observed in the processing of information and the brain activity of patients suffering from psychosis.
Stéphane Potvin is a researcher at the Institut universitaire en santé mentale de Montréal and a full professor in the Department of Psychiatry and Addictology at the University of Montreal. He holds the Eli Lilly Research Chair on Schizophrenia. His research focuses on the harmful role that cannabis or alcohol plays on brain structures in schizophrenics, focusing in particular on the reward system of the brain. Professor Potvin’s research interests also include the mechanisms of modulating the emotional component of pain and the treatment of emotions in cannabis-abusing schizophrenics, using the functional magnetic resonance imaging technique. The works of Professor Potvin are funded by multiple subventions of the Canadian Institutes of Health Research, Fonds de Recherche du Québec, and the Natural Sciences and Engineering Research Council of Canada.
